Bliss Gvs Pharma Ltd vs Vasundhara Rasayans Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Bliss GVS Pharma Ltd is ₹ 284.3 as of 18 May 14:16 . The P/E Ratio of Bliss GVS Pharma Ltd changed from 14.9 on March 2021 to 14.7 on March 2025 . This represents a CAGR of -0.27% over 5 yearsThe P/E Ratio of Vasundhara Rasayans Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Bliss GVS Pharma Ltd changed from ₹ 1018 crore on March 2021 to ₹ 1238 crore on March 2025 . This represents a CAGR of 4.00% over 5 yearsThe Market Cap of Vasundhara Rasayans Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Bliss GVS Pharma Ltd for the Mar '26 is ₹ 268.18 crore as compare to the Dec '25 revenue of ₹ 236.71 crore. This represent the growth of 13.29% The revenue of Vasundhara Rasayans Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Bliss GVS Pharma Ltd for the Mar '26 is ₹ 55.63 crore as compare to the Dec '25 ebitda of ₹ 50.73 crore. This represent the growth of 9.66% The ebitda of Vasundhara Rasayans Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Bliss GVS Pharma Ltd changed from ₹ 22.11 crore to ₹ 37 crore over 8 quarters. This represents a CAGR of 29.36% The net profit of Vasundhara Rasayans Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Bliss GVS Pharma Ltd changed from 7.64 % on March 2021 to 7.64 % on March 2025 . This represents a CAGR of 0.00% over 5 yearsThe Dividend Payout of Vasundhara Rasayans Ltd changed from 16.22 % on March 2021 to 14.96 % on March 2025 . This represents a CAGR of -1.60% over 5 years .

About Bliss GVS Pharma Ltd

Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984.
The status converted into a Public Limited Company and the name of the Company was changed to Bliss Chemicals & Pharmaceuticals India Limited and further to Bliss GVS Pharma Limited on May 12, 2006. The Company is engaged in manufacturing, marketing, trading and export of pharmaceutical products.
The Company has its manufacturing facility at Palghar which is WHO GMP approved.
The business operates five cutting-edge production facilities that adhere to WHO-GMP, EU-MP, ISO 14001 and OHSAS 45001 standards. The company commenced its business in 1985.
In 1994 the company introduced a new pharmaceutical product VAGID. During the financial year ended 31 March 2014, Bliss GVS Pharma's R&D center, received approval from Government of India's Department for Scientific & Industrial Research (DSIR).

About Vasundhara Rasayans Ltd

Vasundhara Rasayans Limited was incorporated in March, 1987.
The Company is the leading manufacturer and exporter of Antacids therapeutic category of Active Pharmaceutical Ingredients with annual capacity of about 1500 MT of powder or its equivalent products.
It started its operation in year 1990 with an Antacid API facility offering product in paste, powder and micronised grade of powder. The plant is located on National Highway between Mumbai and Goa in an Industrial Zone called Mahad which is about 170 KMS from Mumbai and about 125 KMS from the NSICT /JNPT Ports Mumbai.
In addition to the API manufacturing Vasundhara is also having an API intermediate plant to handle organic products with its state of the art specialised Friedel Craft reaction facility. The manufacturing area is maintained as per GMP standards.

FAQs for the comparison of Bliss GVS Pharma Ltd and Vasundhara Rasayans Ltd

Which company has a larger market capitalization, Bliss GVS Pharma Ltd or Vasundhara Rasayans Ltd?

Market cap of Bliss GVS Pharma Ltd is 2,943 Cr while Market cap of Vasundhara Rasayans Ltd is 38 Cr

What are the key factors driving the stock performance of Bliss GVS Pharma Ltd and Vasundhara Rasayans Ltd?

The stock performance of Bliss GVS Pharma Ltd and Vasundhara Rasayans Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bliss GVS Pharma Ltd and Vasundhara Rasayans Ltd?

As of May 18, 2026, the Bliss GVS Pharma Ltd stock price is INR ₹278.2. On the other hand, Vasundhara Rasayans Ltd stock price is INR ₹120.2.

How do dividend payouts of Bliss GVS Pharma Ltd and Vasundhara Rasayans Ltd compare?

To compare the dividend payouts of Bliss GVS Pharma Ltd and Vasundhara Rasayans Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.